J&J, Ovarian Cancer Talc Claimants Unveil $5.5B Global Deal
Johnson & Johnson announced Monday that it has agreed to pay $5.5 billion to put to rest tens of thousands of lawsuits alleging its talcum powder products caused ovarian cancer, with...To view the full article, register now.
Already a subscriber? Click here to view full article